# | ||||
---|---|---|---|---|
1 | EYEPOC Clinical validation of a new diagnostic and monitoring PoC medical device based on quantification of biomarkers in tear fluids to improve the quality of eye health care | 2014 | 71˙429.00 | 50˙000.00 |
The Institution HORUS PHARMA SAS has been involved also in the following Horizon 2020 projects.